ScreenerHero
BANBBachem Holding AG
SWX · CH · Basic Materials · Biotechnology · bachem.com
77.15CHF-0.32%Mkt Cap: 6.62B $P/E: 38.13

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, …

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
ARGENX SE
$60.19BUSDP/E 39.1
UCB
UCB SA
$45.16BUSDP/E 19.2
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.17BUSDP/E 26.2
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap6.62B $
Enterprise Value6.81B $
Revenue (TTM)808.65M $
Gross Profit227.96M $
Net Income (TTM)169.82M $
Revenue/Share10.77 USD
Last Price77.15 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.7K
CountryCH
SectorBasic Materials
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)38.13
P/E (Forward)25.40
PEG0.61
EV/EBITDA28.34
EV/Revenue8.42
P/S8.16
P/B4.01
EPS (TTM)1.98
EPS (Forward)3.04
52W Range
48.5282% of range83.25
52W High83.25 CHF
52W Low48.52 CHF
Profitability
Gross Margin28.74%
Oper. Margin16.59%
EBITDA Margin29.70%
Profit Margin21.41%
ROE10.20%
ROA7.06%
Growth
Revenue Growth4.30%
Earnings Growth0.00%
Cash Flow & Leverage
Operating CF309.95M $
CapEx (TTM)375.94M $
FCF Margin-29.24%
FCF Yield-3.57%
Net Debt178.65M $
Net Debt/EBITDA0.74
Balance Sheet
Debt/Equity14.41
Current Ratio1.60
Quick Ratio0.46
Book Value/Sh19.24 CHF
Cash/Share0.6870 CHF
Dividends
Fwd Div Rate0.9000 CHF
Trail. Div Rate0.9000 CHF
Div. Yield1.17%
5Y Avg Yield1.06%
Payout Ratio45.45%
Ex-Div DateMay 4, 2026
Pay DateMay 7, 2025
Splits
Last Split5:1
Split DateMay 5, 2022
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)82.80 CHF
Upside (mean)+7.3%
Target Range50.00 CHF – 110.00 CHF
CHF50.00+7.3% to meanCHF110.00
# Analysts10
Ownership
Shares Out.74.94M
Float70.78M
Insiders0.25%
Institutions83.16%
Technical
SMA 5073.20 (+5.4%)
SMA 20066.24 (+16.5%)
Beta0.80
S&P 52W Chg18.16%
Avg Vol (30d)119.41K
Avg Vol (10d)89.82K
Technical Indicators
RSI (14)59.6
MACD0.6485
MACD Signal0.4115
MACD Hist.+0.2371
BB Upper77.30 CHF
BB Middle74.64 CHF
BB Lower71.99 CHF
BB Width7.11%
ATR (14)3.205 CHF
Vol Ratio (20d)0.94x